YESMERIQ
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99155779
- Mark type
- Stylized text
- Filed
- 25 Apr 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Maren Perry
Goods and services
- Class 005 — Pharmaceuticals: Sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosis, prevention and/or treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosis, prevention and treatment of dementia, Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, Multiple System Atrophy (MSA), dementia with Lewy bodies, sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's disease, sclerosis, multiple sclerosis, schizophrenia, bipolar disorder, cancer, pain, migraine, headache, Horton's headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood disorders, falls, movement disorders and diseases, tremor, agitation, mania, aggression, autism, melancholia, Tourette's syndrome, restlessness, akathisia, fatigue, somnolence, nausea, Cushing's disease, Adrenogenital syndrome (AGS), narcolepsy, Thyroid Associated Orbitopathy (TAO), Graves Orbitopathy, Hashimoto's Thyroiditis, alcoholism and addiction
Owner
- Longboard Pharmaceuticals, Inc., La Jolla, CA, US
- Longboard Pharmaceuticals, Inc., La Jolla, CA, US
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 20 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 20 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 20 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 18 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Sept 2025 — NON-FINAL ACTION E-MAILED
- 18 Sept 2025 — NON-FINAL ACTION WRITTEN
- 17 Sept 2025 — ASSIGNED TO EXAMINER
- 03 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Apr 2025 — NEW APPLICATION ENTERED